Herpes Simplex Virus Type 1& Type 2 Nucleic Acid Detection Kit (RT-PCR)

• Customization: Available
• Classification: Gynecology
• Type: Gynecology Test Kit
• Certification: CE, ISO13485
• Certificate: ISO, CE
• Transport Package: Box+Carton
• Specification: 401mm*673mm*475mm
• Trademark: OBM/OEM
• Origin: China
• HS Code: 3002150090
• Production Capacity: 5, 000, 000 Pieces/Month

Product Description

Herpes simplex virus type 1 and 2 Nucleic Acid Detection Kit (RT-PCR)

Key Features:

Sensitivity: >95%
Specificity: 100%
Reaction Time: 10mins
Sample:

Vaginal swab: Carefully insert the swab into the vagina about 2 inches (5 cm) past the introitus and gently rotate the swab for 10 to 30 seconds. Make sure the swab touches the walls of the vagina so that moisture is absorbed by the swab and then

withdraw the swab without touching the skin.

Male urethral swab: Insert the specimen collection swab 2 to 4 cm into the urethra.

Gently rotate the swab clockwise for 2 to 3 seconds in the urethra to ensure adequate sampling.

Storage temperature: 2-30ºC

 

 

 

Introduction

Herpes simplex virus type 1/ Herpes simplex virus type 2 Nucleic Acid Assay Kit (RT-PCR) is for in vitro rapid qualitative detection of Herpes simplex virus type 1 and Herpes simplex virus type 2 in female genital tract secretion and male urinary tract secretion. This test kit is suitable for patients with clinical symptoms of sexually transmitted infections (STI) or initial screening of high-risk STI population.

The test results are for clinical reference and should not be regarded as the only standard for clinical diagnosis. It is recommended to combine the patient's clinical manifestations and other laboratory test results for a comprehensive analysis of the condition.

About Medomics

Jiangsu Medomics Medical Technology Co., Ltd., is located at Biotech and Pharmaceutical Valley of the National Jiangbei New Area, Nanjing, Jiangsu Province. It is an international high-tech enterprise driven by innovation in the area of medical devices R&D, production and sales. Medomics focuses on diagnosis of microorganisms, tumors and some rare diseases, mainly engaged in the research and development, production and sales of in vitro diagnostic reagents and automatic instruments.  

Medomics owns two R&D centers in China and the US, independent intellectual property rights of fluorescent staining technology, protein labeling technology, time-resolved immunofluorescence detection technology, image processing and analysis technology and other innovative technology platforms, as well as a total of more than 10,000 square meters of GMP purification production workshop that meets the product standards of FDA, CE and CFDA. Until now, Medomics has more than 100 employees across the world and R&D personnel accounts for over 50%. Medomics also has a multidisciplinary expert team with abundant experience in the industry, including senior experts in immunology, microbiology, applied physics, polymer materials, medical imaging, optical systems, etc. The members of the technical team are led by doctors from many famous institutions, such as Osaka University, North Carolina University, University of Nebraska Lincoln, Zhejiang University, Sichuan University and other institutions.

Certificate

 

Workshop

 

Exhibition

Logistics

Contact Medomics